FDA Inspection
Intervet Inc. (d/b/a Merck Animal Health)Intervet Inc. (d/b/a Merck Animal Health) – FDA Inspection, Aug 6, 2024
Record Details
This FDA Inspection record concerns Intervet Inc. (d/b/a Merck Animal Health), with an inspection on August 6, 2024, issued by the Center for Veterinary Medicine, covering veterinary.
- People
- Ana C. Lazo (Company Rep)
- Jay B. Shah (FDA Associated Person)
- Jordan C. Desilva (Issuing Officer)
- Michael Serrano (Company Rep)
View Company Profile
ID · abd2a72c-2b42-49a7-983d-b97629ff8467
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1236865
- FDA center
- Animal Drugs & Feeds
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 511.1(b)(8)(ii)Sponsor/CRO: Reporting of hazards
- 21 CFR 511.1(b)(8)(ii)Sponsor: Monitoring
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Intervet Inc. (d/b/a Merck Animal Health)
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 15, 2016 | OAI | Center for Veterinary Medicine | Bioresearch Monitoring |
| August 14, 2014 | OAI | Center for Veterinary Medicine | Bioresearch Monitoring |
Other documents for Intervet Inc. (d/b/a Merck Animal Health)
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.